{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:31:54Z","timestamp":1791297114307,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.vaccine.2008.08.064","type":"journal-article","created":{"date-parts":[[2008,9,20]],"date-time":"2008-09-20T08:40:50Z","timestamp":1221900050000},"page":"5981-5988","source":"Crossref","is-referenced-by-count":24,"title":["Attenuated West Nile viruses bearing 3\u2032SL and envelope gene substitution mutations"],"prefix":"10.1016","volume":"26","author":[{"given":"Li","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Robert Putnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Pletnev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Markoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.08.064_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev.med.57.121304.131418","article-title":"West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States","volume":"57","author":"Hayes","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2008.08.064_bib2","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1099\/0022-1317-78-9-2293","article-title":"Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses","volume":"78","author":"Berthet","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.08.064_bib3","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0140-6736(99)05384-2","article-title":"Genetic analysis of West Nile New York 1999 encephalitis virus","volume":"354","author":"Jia","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.08.064_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/viro.2002.1372","article-title":"Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype","volume":"296","author":"Beasley","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib5","series-title":"Fields Virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.vaccine.2008.08.064_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0042-6822(86)90012-7","article-title":"The 3\u2032-nucleotides of flavivirus genomic RNA form a conserved secondary structure","volume":"153","author":"Brinton","year":"1986","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0014-5793(85)80895-4","article-title":"Stable secondary structure at the 3\u2032 end of the genome of yellow fever virus (17D vaccine strain)","volume":"188","author":"Grange","year":"1985","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2008.08.064_bib8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0378-1119(89)90266-7","article-title":"Sequence analysis of cloned dengue virus type 2 genome (New Guinea C strain)","volume":"75","author":"Irie","year":"1989","journal-title":"Gene"},{"key":"10.1016\/j.vaccine.2008.08.064_bib9","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JVI.79.4.2309-2324.2005","article-title":"The topology of bulges in the long stem of the flavivirus 3\u2032 stem\u2013loop is a major determinant of RNA replication competence","volume":"79","author":"Yu","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.064_bib10","doi-asserted-by":"crossref","first-page":"7510","DOI":"10.1128\/JVI.72.9.7510-7522.1998","article-title":"Identification of specific nucleotide sequences within the conserved 3\u2032-SL in the dengue type 2 virus genome required for replication","volume":"72","author":"Zeng","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.08.064_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.virol.2004.08.004","article-title":"Enhancement of dengue virus translation: role of the 3\u2032 untranslated region and the 3\u2032 terminal stem\u2013loop domain","volume":"329","author":"Holden","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib12","first-page":"221","article-title":"Development of the first WNV vaccine licensed for horses","volume":"114","author":"Ng","year":"2003","journal-title":"Biol Basel"},{"key":"10.1016\/j.vaccine.2008.08.064_bib13","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1016\/j.vaccine.2007.09.055","article-title":"Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine","volume":"25","author":"Samina","year":"2007","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.08.064_bib14","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.064_bib15","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1637\/0005-2086(2007)51[573:DVOTAC]2.0.CO;2","article-title":"DNA vaccination of the American crow (Corvus brachyrhynchos) provides partial protection against lethal challenge with West Nile virus","volume":"51","author":"Bunning","year":"2007","journal-title":"Avian Dis"},{"issue":"24","key":"10.1016\/j.vaccine.2008.08.064_bib16","first-page":"40","article-title":"Chimeric West Nile\/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity","volume":"29","author":"Pletnev","year":"2006","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2008.08.064_bib17","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1128\/JVI.79.12.7300-7310.2005","article-title":"Chimeric dengue 2 PDK-53\/West Nile NY99 viruses retain the phenotypic attenuation markers of the candidate PDK-53 vaccine virus and protect mice against lethal challenge with West Nile virus","volume":"79","author":"Huang","year":"2005","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.08.064_bib18","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2008.08.064_bib19","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.vaccine.2008.02.009","article-title":"The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus","volume":"26","author":"Shrestha","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.064_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1006\/viro.2000.0795","article-title":"An infectious clone of the West Nile flavivirus","volume":"281","author":"Yamshchikov","year":"2001","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib21","first-page":"493","article-title":"A simple method for estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2008.08.064_bib22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1128\/JVI.80.3.1427-1439.2006","article-title":"A tick-borne Langat virus mutant that is temperature sensitive and host range restricted in neuroblastoma cells and lacks neuroinvasiveness for immunodeficient mice","volume":"80","author":"Rumyantsev","year":"2006","journal-title":"J Virol"},{"issue":"5448","key":"10.1016\/j.vaccine.2008.08.064_bib23","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2008.08.064_bib24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1099\/0022-1317-76-2-409","article-title":"Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14","volume":"76","author":"Ni","year":"1995","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.08.064_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0042-6822(90)90519-W","article-title":"Nucleotide sequence of the virulent SA-14 strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA-14-14-2","volume":"177","author":"Nitayaphan","year":"1990","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.064_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/JVI.75.2.934-942.2001","article-title":"Molecular basis for attenuation of neurovirulence of a yellow fever Virus\/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE)","volume":"75","author":"Arroyo","year":"2001","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2008.08.064_bib27","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JVI.76.7.3318-3328.2002","article-title":"Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys","volume":"76","author":"Markoff","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2008.08.064_bib28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.biologicals.2005.03.009","article-title":"Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys","volume":"33","author":"Monath","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2008.08.064_bib29","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2004.09.014","article-title":"An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development","volume":"330","author":"Yamshchikov","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib30","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.virol.2006.07.038","article-title":"Immunogenicity of West Nile virus infectious DNA and its noninfectious derivatives","volume":"356","author":"Seregin","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib31","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1128\/JVI.71.9.6433-6444.1997","article-title":"Translation elongation factor-1 alpha interacts with the 3\u2032 stem\u2013loop region of West Nile virus genomic RNA","volume":"71","author":"Blackwell","year":"1997","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.08.064_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00571925","article-title":"Identification of mutations that occurred in the genome of Japanese encephalitis virus during the attenuation process","volume":"5","author":"Aihara","year":"1991","journal-title":"Virus Genes"},{"issue":"6529","key":"10.1016\/j.vaccine.2008.08.064_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/375291a0","article-title":"The envelope protein from tick-borne encephalitis virus at 2\u00c5 resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2008.08.064_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.virol.2006.05.025","article-title":"A mutation in the envelope protein fusion loop attenuates mouse neuroinvasivenes of the NY99 strain of West Nile virus","volume":"353","author":"Zhang","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2008.08.064_bib35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","article-title":"Antigenic structure of flavivirus proteins","volume":"59","author":"Roehrig","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.vaccine.2008.08.064_bib36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8+ T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0801164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0801164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T11:35:57Z","timestamp":1588937757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0801164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":36,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0264410X0801164X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}